China (Mainland)
99% up by HPLC Aniracetam 72432-10-1 CAS NO.72432-10-1
- Min.Order: 25 Kilogram
- Payment Terms: T/T,Other
- Product Details
Keywords
- Aniracetam
- Aniracetam powder
- 72432-10-1
Quick Details
- ProName: Aniracetam
- CasNo: 72432-10-1
- Appearance: white powder
- Application: API
- DeliveryTime: 7days after payment
- PackAge: 25kg/drum
- Port: shanghai/beijing
- ProductionCapacity: 5 Metric Ton/Month
- Purity: 99% up by HPLC
- Storage: Ordinary
- Transportation: by Sea, by Air
- LimitNum: 25 Kilogram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial since 1987
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms.
4) We have warehouse in USA with quickly shipment .
Details
|
Product name |
Aniracetam |
|
CAS No. |
72432-10-1 |
|
Molecular Formula |
C12H13NO3 |
|
Molecular Weight |
219.24 |
|
Quality Standard |
98% up by HPLC |
|
Appearance |
White or off-white crystalline powder |
|
ANALYSIS |
SPECIFICATION |
RESULTS |
|
Appearance |
White or off-white crystalline powder, odorless and a little bitter |
Conforms |
|
Melting Point |
118-122。C |
120.1-121.9。C |
|
Absorbance |
476-506 |
492 |
|
Chemical Reaction |
Generate white precipitate |
Conforms |
|
IR Identification |
Should comply with the reference spectrum |
Comply with the reference spectrum |
|
Related Substances |
||
|
Individual Impurity |
≤0.2% |
0.1% |
|
Total Impurities |
≤0.5% |
0.2% |
|
Residual solvent |
||
|
Methanol |
≤0.3% |
ND |
|
Ethanol |
≤0.5% |
ND |
|
Ethyl Acetate |
≤0.5% |
ND |
|
Toluene |
≤0.089% |
ND |
|
Loss on Drying |
≤0.5% |
0.40% |
|
Residual on Ignition |
≤1.0% |
0.05% |
|
Heavy metals |
≤10ppm |
Conforms |
|
Assay |
98.0% - 102.0% |
101.0% |
|
Microbial Limit |
||
|
Bacterial count |
≤1000cfu/g |
<10cfu/g |
|
Mold and Yeast Count |
≤100cfu/g |
<10cfu/g |
|
Escherichia Coli |
Not detected |
Not detected |
|
Conclusion |
The sample conforms to the Specifications. |
|
|
|
Aniracetam is a γ-lactam-based drug designed to improve brain function.
Aniracetam primarily acts on the nervous system, capable of crossing the blood-brain barrier and selectively targeting the brain. It enhances the metabolism of neurotransmitters, promotes the metabolism of 5-hydroxytryptamine, and effectively shortens selective reaction times. By doing so, it promotes and enhances memory function, improves intelligence, and has neuroprotective effects. Aniracetam also modulates the function of synaptic AMPA receptors and nicotinic acetylcholine receptors (nAChRs), contributing to its neuroprotective and nootropic properties.
Aniracetam is clinically used to treat mild to moderate vascular dementia and Alzheimer's disease, which are associated with learning, memory, and cognitive dysfunction. It is also used to improve memory function after stroke, benign memory disorders in middle-aged and elderly individuals, and developmental delays in children. Animal studies have shown that Aniracetam improves memory reproduction in normal rats and counteracts memory impairment caused by hypoxia.
